Zdrowie i gospodarka · 01/03/2018

FDA Reopens Public Comment Period for Antibacterial and Antifungal Drug Susceptibility Test Interpretive Criteria

The US Food and Drug Administration (FDA) is reopening a public comment period for the susceptibility test interpretive criteria for antibacterial and antifungal drugs, which were initially recognized and listed on the FDA's Susceptibility Test Interpretive Criteria web page established on December 13, 2017.